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Introduction 
Polyamines are physiological cellular constituents essential for cell growth and differentiation, 
and regulate a multitude of cellular functions (1-4). Nitric oxide (NO) is an effector 
molecule in both the cardiovascular and nervous systems (5,6). Intracellularly, NO and 
polyamines are derived from arginine, the latter via the rate-limiting enzyme ornithine 
decarboxylase (ODC; 7). This enzyme, like the inducible nitric oxide synthase (iNOS), is 
induced by proinflammatory cytokines and bacterial lipopolysaccharide (LPS), resulting in 
enhanced enzyme activity and increased polyamine biosynthesis (8,9). While the increase 
in polyamine synthesis would have important implications for cell growth and proliferation, 
it is not clear how this might affect iNOS pathway. 
Inhibition of polyamine biosynthesis impairs the phagocytic capacity of macrophages (10) 
and can block macrophage activation by tumour necrosis factor (11). Recently, exogenous 
polyamines have been shown to inhibit NO production in LPS-activated J774 cells (12) and 
by isolated neuronal NO synthase (13). However, these effects required relatively high 
concentrations of polyamines compared to those found in plasma and in intact cells (14), and 
appear to be due to aldehyde metabolites resulting from polyamine oxidation by the amine 
oxidase present in calf serum (15-17). In this study we have explored the effects of both 
endogenous and exogenous polyamines on the inducible L-arginine-NO pathway by 
examining whether inhibition of ornithine decarboxylase (ODC) and thus of polyamine 
biosynthesis (7), regulates NO production in lipopolysaccharide-activated J774 cells, a murine 
macrophage cell line. 
Methods 
Materials 
Tissue culture reagents, LPS, MTT, NG-monomethyl-L-arginine, EGTA, Dowex (AG 50W-
8), 2-methylornithine (2-MeO) and polyamines were obtained from Sigma (Poole, UK). 
Monoclonal iNOS antibody was from Affiniti Research Products Ltd (Nottingham, UK); 
nitrocellulose membrane from Anderman and Co. (Kingston-upon-Thames, UK); ECL 
detection system from Amersham Life Sciences (Little Chalfont, UK); scanning densitometry 
equipment (UVP E.A.S. Y. Plus Enhanced Analysis System) was from Ultra-Violet Products 
Ltd. (Cambridge, UK). Other chemicals were from either Sigma or Merck and of the 
highest grade obtainable. Difluoromethylornithine (DFMO)was a gift from Marrion Merrell 
Dow, Cincinnati, Ohio, USA. /V'.A^-Diacetylspermine was prepared as described elsewhere 
(18). 
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Cell culture 
J774 cells were maintained in continuous culture in Dulbecco's modified Eagle's medium 
(DMEM) supplemented with 42 mM NaHC03, penicillin (100 units/ml) and streptomycin 
(100 units/ml), 2 mM glutamine and 10% foetal calf serum. Monolayers of cells were 
routinely harvested by gentle scraping with a Teflon cell-scraper, diluted 1:10 in fresh 
medium and cultured to confluency at 37°C For use, cells were resuspended in fresh 
medium containing either foetal calf or horse serum at 5 χ 105 cells/ml. Aliquots (200 μΐ) 
were dispensed into the inner 60 wells of 96-well tissue culture plates, the outer wells of 
which each contained 200 μΐ phosphate-buffered saline (140 mM NaCl, 2.7 mM KCl, 8.1 
mM Na2HP04, 1.5 mM KHP04, pH 7.4). 
Measurement of iNOS activity 
Confluent monolayers of cells were activated with Eschericia coli lipopolysaccharide (LPS, 
serotype 0111:B4; 0.1 μg/ml) alone or in combination with inhibitor (1-10 mM) and, or, 
polyamines (25-100 μΜ). When applied, inhibitor was either added simultaneously with LPS 
or pre-incubated with cells for 24 or 48 h prior to stimulation with LPS. Two protocols for 
cell treatment were used. In the first (Protocol 1) culture medium was replaced with fresh 
medium plus treatment (inhibitor, polyamine) every 24 h; in the second (Protocol 2), all 
treatments were added directly into the existing culture medium without replacing the latter. 
Nitrite production was assayed after 24 h by measuring the accumulated levels in the culture 
medium using the Griess reaction (19), as described previously (20). 
Cell Viability 
Cell viability was monitored by measuring the mitochondrial-dependent reduction of (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; MTT) to formazan (21). Briefly, 
after each experimental protocol, cells in 96-well plates were incubated with MTT (0.5 mg 
ml"1) for 4 h at 37°C An equal volume of 10% SDS in 0.01 M HCl was then added to all 
wells and incubated for a further 3 h to dissolve the accumulated crystals of formazan. 
Absorbance was read at 560 nm using a Multiskan II plate reader (Titertek). In some 
experiments the formazan was solubilised using dimethylsulphoxide (22). 
Polyamine transport 
Uptake of radiolabelled polyamines (0.25-10 μΜ) was measured in cells cultured in 96-well 
plates for 24 h in the presence or absence of LPS (1 μg/ml) essentially as described 
elsewhere (23,24). Briefly, cell monolayers were rinsed with HEPES-buffered Hanks 
balanced salt solution, then incubated with 0.25-10 μΜ radiolabelled polyamine 
(approximately 100 μΟί/πιΜοΙ) in HEPES-Hanks. After 15 min incubation the plates were 
placed in melting ice and ice-cold PBS added to each well. After three rinses with PBS, the 
protein content of the cell monolayers was measured using Coomassie Blue (25). Cell 
material was then dissolved in formic acid (25 M) and the amount of radioactivity taken up 
determined by liquid scintillation counting. Apparent kinetic constants were derived by 
computer fitting the uptake data (calculated as pmol^g protein/h) to Michaelis-Menten plots. 
Assay of isolated iNOS activity 
Cells (approximately 9.5 χ IO6) in 75 cm2 culture flasks were activated with LPS (1 mg/ml) 
for 18 h then harvested by scraping into 1 ml of homogenization buffer (50 mM Tris-HCl, 
320 mM sucrose, 1 mM EDTA, 1 mM dithiothreitol, 10 μg/ml leupeptin, 10 μg/ml soybean 
trypsin inhibitor and 2 mg/ml aprotinin). The cells were lysed by three cycles of freezing 
(-70°C) and thawing (37°C) then the lysate was centrifuged for 60 min at 10,000 g, 4°C 
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Activity of iNOS in the cell-free supernatant was determined by monitoring the conversion 
of L-(3H)arginine to L-(3H)citrulline (26), in the presence or absence of A^-monomethyl-L-
arginine (L-NMMA; 100 μΜ), EGTD (1 mM), DFMO (1-10 mM), or polyamines (0.001-1 
mM). Briefly, 20 μΐ of 10,000 g supernatant, plus compound of choice, was added to 100 
μΐ of assay buffer (50 mM KH2P04, 1 mM MgCl2, 0.2 mM CaCl2, 50 mM valine, 1 mM 
dithiothreitol, 100 mM NADPH, 1 mM L-citrulline, 20 mM L-arginine and 0.5 mCi/ml L-
(3H)arginine) and incubated for 20 min at 37°C Unreacted (3H)arginine was removed by 
adding 1 ml of a 1:1 suspension of Dowex (AG 50W-8) in water to each sample. The 
supernatant, containing the (3H)citrulline, was transferred into ß­vials and radioactivity 
measured by liquid scintillation counting. 
Western blot analysis of iNOS expression 
Confluent monolayers of J774 cells in 24­well culture plates (5 χ IO5 cells/well) were pre­
incubated with either DMEM alone or with DMEM containing DFMO (10 mM). The 
medium was removed after 24 h and replaced with fresh DMEM or with DMEM containing 
LPS (1 μg ml"1) and/or DFMO (10 mM). Incubations were terminated after 18 h by rapid 
aspiration of the cell supernatant followed by washing with ice­cold PBS. The cell 
monolayers were lysed in buffer (63.5 mM Tris­HCl, pH 6.8; 10% glycerol, 2% SDS, 5% 
2­mercaptoethanol, 1 mM 4­(2­aminoethyi)­benzenesufonylfluoride and 50 mg/ml leupeptin). 
Samples were then probed for iNOS protein levels as described previously (27). Briefly, 
lysates (20 μg protein/lane) were separated by SDS­PAGE on 8% Polyacrylamide gel, then 
transferred onto nitrocellulose membrane. Membranes were blocked in STT (100 mM NaCl, 
10 mM Tris, 0.1% (v/v) Tween­20, pH 7.4 containing 1% (w/v) BSA), then probed 
overnight with mouse monoclonal anti­iNOS antibody. Blots were washed with STT and 
incubated with horseradish peroxidase­conjugated rabbit anti­mouse IgG. After further 
washing in STT, immunoreactive bands were visualised using the ECL detection System. 
Protein bands were quantified by scanning densitometry and the data expressed as a 
percentage of the value obtained for samples from cells treated with LPS alone. 
Statistics 
All values are means ± SEM of measurements from at least three different experiments with 
5­10 replicates in each. Statistical analyses were performed using a multiple means 
comparison test ((28); validated using the Longley set of 'stiff data (29,30) with the overall 
confidence levels set at 99% (P<0.01). 
Results 
Effects of DFMO on LPS-stimulated nitrite production 
Incubation of J774 cells with LPS (0.1 μg/ml) according to Protocol 1 stimulated NO 
production from a basal value of 0.02 ± 0.003 to 0.76 ± 0.01 nmole^g protein/24 h 
(n=13). This increase in nitrite production was further potentiated, dose­dependently, by 
DFMO, which at 10 mM (added 24 h before LPS) increased nitrite levels by a further 52 ± 
5.9% (Figure 1). Similar results were obtained when 2­MeO was substituted for DFMO. 
This response is not dependent on sera type since DFMO potentiation occurred in the 
presence of either foetal calf or horse serum (Table 1). 
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Figure 1. Concentration­dependent potentiation of LPS­induced nitrite production in J774 
macrophages by 2­difluoromethylornithine (DFMO). Cells cultured in calf serum­con tai η ing 
medium were incubated with DFMO for 24 h prior to activation with LPS (0.1 μg/ml). 
Nitrite was determined after a further 24 h. Results are expressed as % of the LPS response. 
Values are means ± SEM of 5 independent experiments with 5 replicates in each. All values 
in the DFMO­treated group are significantly different from LPS alone (P<0.01). 
Table 1. Effects of foetal calf or horse serum on potentiation of LPS­induced nitrite 
production by DFMO. 
Nitrite (nmole^g protein/24 h) 
Foetal calf serum (10%) Horse serum (10%) 
Control 
DFMO (10 mM) 
LPS (0.1 μg/ml) 
LPS + DFMO 
0.004 ± 0.001 
0.006 ± 0.002 
0.60 ± 0.04 
0.91 ± 0.06* 
0.001 ± 0.005 
0.004 ± 0.006 
0.56 ± 0.005 
0.83 ± 0.02* 
*P<0.01 compared to LPS alone 
Although addition of DFMO simultaneously with, or for 48 h prior to LPS, enhanced 
nitrite levels, the increases observed were relatively less compared to those seen after 24 h 
pre­treatment (Figure 2). Addition of DFMO for 48 h without replacement of medium, 
followed by activation of cells with LPS, again without replacement of medium (Protocol 2) 
resulted in a marked decrease in nitrite levels of approximately 50%, compared to LPS 
alone (31). Supplementation of the medium with 1 mM exogenous arginine did not reverse 
the inhibition caused by DFMO. Replacement of DFMO by 2­MeO gave similar results. 
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Figure 2. Time-dependent potentiation of LPS-induced nitrite production in J774 
macrophages by DFMO. Cells cultured in calf serum-containing medium were incubated 
with DFMO (10 mM) for 0, 24 or 48 h prior to activation by adding LPS (0.1 μg/ml). 
Accumulated nitrite was determined after a further 24 h. Results are expressed as % of the 
LPS response. Values are means ± SEM of 5 independent experiments with 5 replicates in 
each. All values in the DFMO-treated group are significantly different from LPS alone 
(P<0.01). 
The potentiation of LPS-stimulated nitrite production by DFMO (Protocol 1) was 
critically time dependent in that the effect was greater when cells were pre-incubated with 
DFMO for 24 h prior to activation with LPS. Addition of DFMO simultaneously with, or 
up to 12 h after, LPS resulted in a time-dependent decrease in the ability of DFMO to 
enhance nitrite levels, independent of serum type (Table 2). Incubation of cells for up to 48 
h with DFMO in the absence of LPS, using either protocol, failed to enhance nitrite 
accumulation above basal values. Furthermore, mitochondrial reduction of MTT to formazan 
was not significantly altered under any of the conditions examined, suggesting that inhibition 
of ODC by either DFMO (irreversible) or 2-MeO (reversible) does not cause any adverse 
effects to J774 cells even when applied at high concentrations and for prolonged periods. 
Table 2. Time-dependent regulation of LPS-induced nitrite production by DFMO. 
Nitrite 
(nmoles^g protein/24 h) 
Control 
LPS (0.1 μg/ml) 
LPS (0.1 μ^πιί) + DFMO (10 mM) 3 h post LPS 
LPS (0.1 μg/ml) + DFMO (10 mM) 6 h post LPS 
LPS (0.1 μg/ml) + DFMO (10 mM) 12 h post LPS 
0.004 
0.60 
0.77 
0.70 
0.63 
± 0.001 
+ 0.04 
± 0.06* 
+ 0.03** 
+ 0.04 
*P<0.01, **P<0.05 compared to LPS alone 
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Table 3. Effects of exogenous polyamines, added concomitantly with agonist, on nitrite 
release from LPS­activated J774 cells cultured in horse serum­containing medium. 
Polyamine Concentration (μΜ) 
0 10 20 50 100 
Putrescine 100 ± 1 104 ± 2 103 ± 1 97 ± 2 93 ± 3* 
/V'­acetylputrescine 100 ± 1 101 ± 3 102 ± 1 98 ± 3 93 ± 1* 
Spermidine 100 ± 1 103 ± 1 99 ± 3 97 ± 3 95 ± 2 
/V'­acetylspermidine 100 ± 3 105 ± 3 105 ± 1 99 ± 5 94 ± 5 
A^­acetylspermidine 100 ± 3 107 ± 1 107 ± 2 102 ± 4 100 ± 2 
Spermine 100 ± 1 105 ± 1 103 ± 3 91 ± 7* 87 ± 4* 
/V'­acetylspermine 100 ± 1 107 ± 2 107 ± 2 93 ± 9* 90 ± 7* 
W',W12­diacetylspermine 100 ± 1 105 ± 3 105 ± 2 95 ± 7 98 ± 5 
Values are percentages of controls (LPS only); *P<0.01 compared to controls 
Effects of polyamines on LPS-stimulated nitrite accumulation 
Addition of exogenous polyamines did not increase nitrite release from LPS­stimulated J774 
cells cultured in medium containing horse serum (Table 3). Slight inhibition (5­6%) was 
observed at 100 μΜ. In contrast, and as shown by others (12,13,17), 50 μΜ spermine 
reduced LPS­stimulated nitrite release by 57% in the presence of calf serum­ (Table 4), but 
by only 8% in horse serum­containing medium, which has lower levels of amine oxidase 
(32). This was increased to 68% and 13%, respectively, at 100 μΜ spermine. In the 
absence of LPS polyamines, at concentrations up to 1 mM, did not alter basal levels of nitrite 
release. 
Table 4. Effects of exogenous spermine, added concomitantly with agonist, on nitrite 
release, from LPS­activated J774 cells cultured in foetal calf serum­containing medium. 
Nitrite 
(nmol/g protein/24 h) 
Control 0.08 ± 0.03 
LPS (0.1 Mg/ml) 1.64 ± 0.31 
Spermine (μΜ) 10 1.78 ± 0.10 
20 1.75 ±0.13 
50 0.68 ± 0.08* 
100 0.53 ± 0.09* 
♦Significantly less than LPS values (P<0.01) 
Effects of LPS-stimulation on polyamine transport 
Uptake was linear with time up to 30 min and was temperature­dependent, being reduced 
approximately 3­fold at 0°C compared to 37°C Putrescine uptake was non­saturable, being 
linear with concentration up to 10 μΜ, and was significantly enhanced (P<0.01) by 
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approximately 30% in the presence of LPS. Uptake of spermidine and spermine could be 
modelled by Michaelis-Menten kinetics (Table 5), LPS treatment reduced the rate of uptake 
but did not affect binding of polyamine to transporter (33). 
Table 5. Kinetic constants for spermidine and spermine transport by J774 cells. 
Spermidine 
K„ 
Spermine 
K„ 
LPS 
LPS3 
7.3 ± 0.5 
7.5 + 0.4 
70 
20 
2.3 ± 0.2 
2.5 + 0.2 
89 ± 5 
56 + 2 
1 μΜ; 2 pmol^g protein/h; 3 1 μg/ml 
Effects of polyamines or ornithine on DFMO modulation of LPS-stimulated nitrite production 
Addition of putrescine (25-100 μΜ) concomitantly with DFMO did not enhance the 
potentiating effect (Protocol 1) but, in experiments in which DFMO or 2-MeO inhibited 
nitrite release (Protocol 2), this was reversible by exogenous putrescine in both foetal calf 
and horse serum-containing medium (Figure 3). Supplementation of the culture medium with 
ornithine (5 mM) did not alter basal or LPS-stimulated nitrite release in the presence or 
absence of DFMO, although ornithine can inhibit arginine uptake in these cells (Baydoun, 
unpublished data). Again, replacement of DFMO by 2-MeO gave similar results. 
Effects of DFMO or polyamines on iNOS activity 
In order to ascertain whether DFMO altered the activity of iNOS once induced, experiments 
were carried out to explore the direct effects of DFMO or polyamines on enzyme activity by 
monitoring the conversion of L-(3H)arginine to citrulline using lysates from LPS-activated 
J774 cells. Unstimulated J774 cells had no detectable levels of NOS activity. Following 
activation with LPS (1 mg/ml) total NOS activity was significantly elevated (159 ± 11 
pmoles L-(3H)citrulline mg protein"' 20 min"1; η=3) and was unaffected by removal of 
calcium from the reaction buffer using 1 mM EGTA. Conversion of L-(3H)arginine to 
citrulline was, however, markedly attenuated by L-NMMA, which at 100 mM inhibited L-
(3H)citrulline production by 79%. In contrast neither DFMO (1-10 mM) nor putrescine, 
spermidine, or spermine (0.001-1 mM) inhibited conversion of (^arginine to (3H)citrulline 
(Table 6). 
Western blot analysis 
To determine whether the potentiation caused by DFMO was due to the enhanced iNOS 
expression, Western blot analysis was carried out on whole cell lysates using a monoclonal 
antibody for murine iNOS. In lysates from LPS-activated (1 mg/ml; 24 h), but not from 
untreated cells, the iNOS antibody recognised a protein band which migrated at a molecular 
weight of - 130 kDa. The levels of iNOS protein, determined by scanning densitometry, 
were significantly enhanced in lysates from J774 cells activated with LPS in the presence of 
DFMO (10 mM; 24 h pre-LPS; Figure 4). 
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Figure 3. Inhibition of LPS-induced nitrite accumulation by 2-MeO and its reversal by 
polyamines. 
Table 6. Effects of DFMO, putrescine, spermidine and spermine on cytosolic iNOS activity. 
L-(H3)citrulline production* 
Control 
+ EGTA ImM 
+ L-NMMA 100 μΜ 
+ DFMO 1.0 mM 
2.5 mM 
5.0 mM 
10.0 mM 
+ Putrescine 1 μΜ 
10 μΜ 
100 μΜ 
1000 μΜ 
+ Spermidine 1 μΜ 
10 μΜ 
100 μΜ 
1000 μΜ 
+ Spermine ΙμΜ 
10 μΜ 
100 μΜ 
1000 μΜ 
100 
103 
30 
103 
101 
104 
106 
113 
90 
112 
111 
98 
101 
108 
111 
102 
96 
101 
91 
*Values, as % activity of enzyme alone, are from 2-3 experiments with 3 replicates in each 
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Figure 4. Western blot analysis of iNOS expression in J774 macrophages. Expression of 
iNOS protein in whole cell lysates was detected using a selective monoclonal antibody 
followed by scanning densitometry: 1, unstimulated cells (control); 2, cells + DFMO (10 
mM; 48 h); 3, cells + LPS (0.1 Mg/ml, 24 h); 4, cells + DFMO (10 mM, 48 h), + LPS 
(0.1 Mg/ml, 24 h). 
Discussion 
The present study demonstrates that pre-incubation of J774 macrophages with DFMO, an 
irreversible inhibitor of ODC, or 2-MeO, a reversible inhibitor, potentiates LPS-induced 
nitrite production when the medium is changed every 24 h. This effect, which is associated 
with an increase in iNOS protein, is not mediated by a direct action of DFMO or polyamines 
on iNOS since addition of DFMO or putrescine, spermidine or spermine to cell lysates did 
not inhibit enzyme activity, measured by the conversion of L-(3H)arginine to L-(3H)citrulline. 
Thus the effects observed may involve regulation of iNOS expression at the molecular level. 
Incubation with DFMO reduces intracellular putrescine and spermidine levels by 60-70% at 
24 h and to below detectable levels at 48 h, although spermine concentrations are unaffected 
(34). Depletion of intracellular putrescine and spermidine by 24 h of DFMO treatment, leads 
to a marked decrease in the rate of cell replication. Exposure of macrophages to LPS results 
in enhanced activity and expression of ODC, which reaches a maximum at 4 h, and which 
precedes the rise in iNOS activity (maximal at 12 h) and subsequent nitrite release, which 
begins to plateau at 24 h (35-37). Since the only known action of DFMO to date involves 
inhibition of ODC (7), it is therefore reasonable to conclude that this novel effect of DFMO 
results from depletion of intracellular putrescine and, or, spermidine pool(s). More 
importantly, our data suggest that expression of iNOS, at least in vitro, may be critically 
regulated by endogenous polyamines. Thus, by preventing this increase in ODC activity, 
DFMO may have a downstream effect on the induction of NO synthase. However, addition 
of exogenous polyamines did not alter the potentiating effect of DFMO on nitrite release. 
Although pre-incubation of cells with DFMO prior to activation potentiated nitrite 
production, addition of the drug to cells several hours after LPS caused only marginal 
changes in accumulated nitrite levels, suggesting that the actions of the two agents are 
temporally related. 
Pre-incubation of J774 macrophages with DFMO, or 2-MeO, without change of medium, 
results in inhibition of LPS stimulated nitrite release and this is reversible by exogenous 
putrescine, the product of ornithine decarboxylation and precursor of spermidine and 
spermine (3,4). The inhibitory effects of both DFMO and 2-MeO on nitrite production were 
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not reversed by excess L-arginine, suggesting that substrate availability was not a limiting 
factor. Not surprisingly, exogenous ornithine also did not alter the effects of DFMO. 
Adequate intracellular levels of polyamines are necessary for optimal cell growth and 
replication of all cell types examined so far. Intracellular concentrations of the polyamines 
are in the high micromolar range and at physiological pH all their amino groups will be 
positively charged. Hence the majority of the polyamines will be sequestered in some way 
and it is probable that only the 'free' polyamine pool is physiologically active. Polyamines 
can influence the transcriptional and translational stages of protein synthesis (38), stabilise 
membranes (39), alter intracellular free calcium levels (40-42), and have important 
neurophysiological functions (43). 
In contrast to the findings reported by Sazbò et al. (12,17), it is unlikely that the effects 
observed in our study involve aldehydes. The acetylation of primary amino groups is the 
first step in the intracellular metabolism of polyamines (44). This is followed by oxidation 
by an intracellular polyamine oxidase (for review see reference 15), resulting in the 
production of acetylated aldehydes which are relatively inactive and non-cytotoxic (18). 
Modulation of LPS-induced nitrite production by DFMO does not appear to be dependent on 
extracellular amine oxidases, in that the effects observed were similar in both foetal calf and 
horse serum, although the latter has much lower levels of amine oxidases (32). 
The apparent conflict between the these results and those published earlier (31) could be 
a consequence of the response of the cells to the growth stimulus resulting from the 
application of fresh serum-containing medium, which would also supply small quantities of 
polyamines. Treatment with DFMO, although reducing intracellular putrescine and 
spermidine to trace levels, does not completely abolish ODC activity and hence small 
amounts of putrescine may be formed and will transiently alter the intracellular pool of 'free' 
polyamines. Addition of fresh serum-containing medium to cultured cells will induce both 
ODC and 5-adenosylmethionine decarboxylase, which regulates the synthesis of spermidine 
and spermine from putrescine (45,46). Furthermore, growth factors are known to increase 
polyamine transport (47) in addition to their inductive effects on ODC (48,49). Also, as 
shown here, LPS increases putrescine transport in macrophages. Hence, under these 
circumstances, despite the presence of DFMO, sufficient putrescine and/or spermidine may 
be available for the synthesis of iNOS protein. Without the inductive effect of fresh serum 
on ODC synthesis and polyamine uptake, the free putrescine/spermidine pools could be 
below the levels required for efficient iNOS synthesis. 
We conclude that alteration of intracellular polyamine levels, in particular the pool of 
'free' putrescine or spermidine, activates a signalling pathway regulating the activity and/or 
stability of iNOS under both physiological and pathophysiological conditions. Our findings 
could also account, at least in part, for the cytostatic, and indeed antitumour, properties of 
DFMO. 
Acknowledgements 
This work was supported by the British Heart Foundation. We thank Marrion Merrell-Dow 
for the gift of DFMO. 
References 
1. Cohen, S.S. (1998). A Guide to the Polyamines. Oxford University Press, New York, 
USA. 
2. Morgan, D.M.L. (1987). Essays Biochem. 23, 82-115. 
Morgan and Baydoun 125 
3. Morgan, D.M.L. (1998). In: Polyamine Protocols (Morgan, D.M.L., ed) pp. 3-30. 
Humana Press, Totowa, NJ. 
4. Jänne, L, Alhonen, L. and Leionen, P. (1991). Ann. Med. 23, 241-259. 
5. Moneada, S., Palmer, R.M.J, and Higgs, E.A. (1991). Pharmacol. Rev. 43, 109-142. 
6. Bredt, D.S. and Snyder, S.H. (1994). Annu. Rev. Biochem. 63, 175-195. 
7. McCann, P.P. and Pegg, A.E. (1992). Pharmacol. Ther. 54, 195-215. 
8. Taffet, S.M. and Haddox, M.K. (1985). J. Cell. Physiol. 122, 215-220. 
9. Tjandrawinata, R.R., Hawel, L. and Byus, C.V. (1994). J. Immunol. 152, 3039-3052. 
10. Kierszenbaum, F., Wirth, J.L, McCann, P.P. and Sjoerdsma, A. (1987). Infect. Immun. 
55, 2461-2464. 
11. Kaczmarek, L., Kaminska, B., Messina, L., Spampinato, G., Arcidiacono, A. 
Malaguamera, L. and Messina, A. (1992). Cancer Res. 52, 1891-1894. 
12. Szabó, C , Southan, G.J., Wood, E., Thiemermann, C and Vane, LR. (1994). Br. J. 
Pharmacol. 112, 355-356. 
13. Hu, L, Mahmoud, M.I. and El-Fakahany, E.E. (1994). Neurosa. Lett. 175, 41-45. 
14. Morgan, D.M.L. (1990). Biochem. Soc. Trans. 18, 1080-1084. 
15. Morgan, D.M.L. (1989). In: Physiology of the Polyamines, Volume 1 (Bachrach, U. and 
Heimer, Y., eds) pp. 203-229. CRC Press, Boca Raton FL. 
16. Southan, G.J., Szabó, C and Thiemermann, C (1994). Biochem. Biophys. Res. 
Commun. 203, 1638-1644. 
17. Szabó, C , Southan, G.J., Thiemermann, C and Vane, LR. (1994). Br. J. Pharmacol. 
113, 757-766. 
18. Morgan, D.M.L. (1987). Biochem. J. 242, 347-352. 
19. Green, L.C, Wagner, D.A., Glogowski, J., Skipper, P.L., Wishnok, LS. and 
Tannenbaum, S.R. (1982). Anal. Biochem. 126, 131-138. 
20. Baydoun, A.R., Bogle, R.G., Pearson, J.D. and Mann, G.E. (1993). Br. J. Pharmacol. 
110, 1401-1406. 
21. Mossman, T. (1983). J. Immunol. Methods 65, 55-63. 
22. Morgan, D.M.L. (1998). In: Polyamine Protocols (Morgan, D.M.L., ed) pp. 179-183. 
Humana Press, Totowa, NJ. 
23. Morgan, D.M.L. (1992). Biochem. J. 286, 413-417. 
24. Morgan, D.M.L. (1998). In: Polyamine Protocols (Morgan, D.M.L., ed) pp. 139-147. 
Humana Press, Totowa, NJ. 
25. Bradford, M.M. (1976). Anal. Biochem., 72, 248-254. 
26. Brown, J.L., Tepperman, B.L., Hanson, P.J., Whittle, B.L'R. and Moneada, S. (1992). 
Biochem. Biophys. Res. Commun. 184, 680-685. 
27. Cirino, G., Wheeler-Jones, CP.D., Wallace, J.L., De Soldato, P. and Baydoun, A.R. 
(1996). Br. J. Pharmacol. 117, 1424-1426. 
28. Harper, J.F. (1984). Comput. Biol. Med. 14, 437-445. 
29. Lachenbruch, P.A. (1983). Byte 8, 560-570. 
30. Wilson, S.R. (1983). Comp. Statist. Data Anal. 1, 29-39. 
31. Morgan, D.M.L. (1994). Biochem. Soc. Trans. 22, 389S. 
32. Blaschko, H. (1962). Adv. Comp. Physiol. Biochem. 1, 67-116. 
33. Cardozo, L., Baydoun, A.R. and Morgan, D.M.L. (1997). 97' European Polyamine 
Conference, Paris. Abstr. 
34. Mamont, P.S., Duchesne, M-C, Grove, J. and Bey, P. (1978). Biochem. Biophys. R 
es. Commun. 81, 58-66. 
35. Nichols, W.K. and Prosser, F.H. (1980). Life Sei. 27, 919-920. 
126 Polyamine regulation of nitric oxide production 
36. Prosser, F.H., Schmidt, C.J., Nichols, S.V. and Nichols, W.K. (1984). J. Cell. Physiol. 
120, 75-82. 
37. Assreuy, L, Cunha, F. Y., Liew, F. Y. and Moneada, S. (1993). Br. J. Pharmacol. 108, 
833-837. 
38. Pegg, A.E. (1986). Biochem. J. 234, 249-262. 
39. Schuber, F. (1989). Biochem. J. 260, 1-10. 
40. Morgan, D.M.L., Coade, S.B. and Pearson, J.D. (1990). Biochem. Soc. Trans. 18, 
1223-1224. 
41. Groblewski, G.E., Hargittai, P.T. and Seidel, E.R. (1992). Am. J. Physiol. Cell 
Physiol. 262, C1356-C1363. 
42. Khan, N.A., Sezan, Α., Quemener, V. and Moulinoux, J.-P. (1993). J. Cell. Physiol. 
157, 493-501. 
43. Carter, C (1994). Neuropharmacology of Polyamines. Academic Press, San Diego. 
44. Casero, R.A. and Pegg, A.E. (1993). FASEBJ. 7, 653-661. 
45. Morrison, R.F. and Seidel, E.R. (1995). Cardiovasc. Res. 29, 841-847. 
46. Blachowski, S., Motyl, T., Grzelkowska, K., Kasterka, M., Orzechowski, A. and 
Interewicz.B. (1994). Int. J. Biochem. 26, 891-897. 
47. Endean, E., Toursarkissian, B., Buckmaster, M., Aziz, S., Gellin, G. and Hill, Β. 
(1996). Growth Factors 13, 229-242. 
48. Higaki, I., Matsui-Yuasa, I., Terakura, M., Kinoshita, H. and Otani, S. (1993). 
Hepatology 17, 99-102. 
49. Ishikawa, T., Mitsuhashi, M., Ichikawa, Y. and Tarnawski, A. (1994). Life Sci. 54, 
1329-1334. 
